Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

2.5K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K
Skin Cancer01:30

Skin Cancer

5.2K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
5.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.0K
Cancer Therapies02:49

Cancer Therapies

8.1K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.1K
Cancer Therapies02:49

Cancer Therapies

2.4K
2.4K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Payer-Negotiated Prices in the Diagnosis and Management of Cutaneous Melanoma in 2025.

JCO oncology practice·2026
Same author

Dermatofibrosarcoma protuberans: A clinical review of diagnosis and management.

Journal of the American Academy of Dermatology·2026
Same author

Risk of new-onset hair loss with semaglutide and tirzepatide: A TriNetX cohort study.

Journal of the American Academy of Dermatology·2026
Same author

Commentary on "Impact of climate and UV variables on melanoma incidence across United States counties".

Journal of the American Academy of Dermatology·2026
Same author

Higher socioeconomic status and physician accessibility linked to more early-stage but not fewer late-stage melanoma diagnoses.

Clinical and experimental dermatology·2025
Same author

Risk of pediatric infections following dupilumab treatment for atopic dermatitis: A TriNetX cohort study.

Journal of the American Academy of Dermatology·2025

Related Experiment Video

Updated: Apr 26, 2026

A 3D Organotypic Melanoma Spheroid Skin Model
08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

18.1K

Current systemic therapies for melanoma.

Darren M Palathinkal1, Timmie R Sharma, Henry B Koon

  • 1*School of Medicine, Case Western Reserve University, Cleveland, Ohio; †Department of Hematology and Oncology, Seidman Cancer Center, University Hospitals Case Medical Center and School of Medicine, Cleveland, Ohio; ‡Department of Dermatology, University Hospitals Case Medical Center and School of Medicine, Case Western Reserve University, Cleveland, Ohio.

Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|July 30, 2014
PubMed
Summary

New systemic therapies for advanced melanoma, including vemurafenib and ipilimumab, show improved survival over older treatments. However, a significant need for more effective and less toxic melanoma treatments persists.

More Related Videos

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma
09:52

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma

Published on: January 25, 2015

12.8K
A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

2.3K

Related Experiment Videos

Last Updated: Apr 26, 2026

A 3D Organotypic Melanoma Spheroid Skin Model
08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

18.1K
Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma
09:52

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma

Published on: January 25, 2015

12.8K
A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

2.3K

Area of Science:

  • Oncology
  • Dermatology
  • Pharmacology

Background:

  • Systemic agents are crucial for melanoma adjuvant therapy and metastatic disease treatment.
  • Interferon-alfa (IFN-α) is the sole approved adjuvant therapy; six drugs (dacarbazine, IL-2, vemurafenib, ipilimumab, dabrafenib, trametinib) are approved for metastatic melanoma.
  • Vemurafenib and ipilimumab gained FDA approval in 2011, followed by dabrafenib and trametinib in 2013.

Purpose of the Study:

  • To provide dermatologists with an update on systemic melanoma therapies.
  • To compare the efficacy, adverse events, and costs of available systemic treatments for melanoma.

Main Methods:

  • A review of current literature on systemic therapies for advanced melanoma.
  • Literature search focused on "advanced melanoma," "systemic therapy," and "adjuvant therapy" over the past 20 years.

Main Results:

  • Prior to 2011, dacarbazine and IL-2 were the primary FDA-approved metastatic melanoma treatments, with IFN-α as the only adjuvant option.
  • Newer agents (vemurafenib, ipilimumab, dabrafenib, trametinib) represent the first systemic therapies to demonstrate improved overall survival in Phase III trials compared to existing treatments.

Conclusions:

  • Despite recent advancements, there is a critical need for improved melanoma therapies.
  • Future treatments must offer enhanced long-term efficacy and reduced toxicity for patients with advanced melanoma.